Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease (E-HART)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03062176
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:17.823638+00:00
Published At
2019-05-17T00:00:00+00:00
Record Updated At
2019-05-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Heart Failure, Systolic", "Renal Disease, End Stage", "Chronic Kidney Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-05-17"
protocolSection.identificationModule.nctId
"NCT03062176"
protocolSection.identificationModule.officialTitle
"Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease (E-HART)"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Heart Failure, Systolic (protocolSection.conditionsModule.conditions)
  • Renal Disease, End Stage (protocolSection.conditionsModule.conditions)
  • Chronic Kidney Diseases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.